SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-11-067458
Filing Date
2011-12-02
Accepted
2011-12-02 16:26:01
Documents
8
Period of Report
2011-12-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a11-31036_18ka.htm 8-K/A 31366
2 EX-99.1 a11-31036_1ex99d1.htm EX-99.1 6754
3 EX-99.2 a11-31036_1ex99d2.htm EX-99.2 10741
4 GRAPHIC g310361moi001.jpg GRAPHIC 3549
5 GRAPHIC g310361moi002.jpg GRAPHIC 1910
6 GRAPHIC g310361moi003.jpg GRAPHIC 3541
7 GRAPHIC g310361mmi001.jpg GRAPHIC 3549
8 GRAPHIC g310361mmi002.jpg GRAPHIC 1853
  Complete submission text file 0001104659-11-067458.txt   70608
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-30319 | Film No.: 111240736
SIC: 2834 Pharmaceutical Preparations